9-134795060-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000093.5(COL5A1):​c.2701-22C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.587 in 1,609,636 control chromosomes in the GnomAD database, including 281,966 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 33155 hom., cov: 32)
Exomes 𝑓: 0.58 ( 248811 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.278

Publications

14 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 9-134795060-C-T is Benign according to our data. Variant chr9-134795060-C-T is described in ClinVar as Benign. ClinVar VariationId is 255069.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.824 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.2701-22C>T intron_variant Intron 32 of 65 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.2701-22C>T intron_variant Intron 32 of 65 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.2701-22C>T intron_variant Intron 32 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.2701-22C>T intron_variant Intron 32 of 65 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.2701-22C>T intron_variant Intron 32 of 65 2 ENSP00000360885.4 P20908-2H7BY82

Frequencies

GnomAD3 genomes
AF:
0.649
AC:
98523
AN:
151908
Hom.:
33113
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.832
Gnomad AMI
AF:
0.356
Gnomad AMR
AF:
0.542
Gnomad ASJ
AF:
0.610
Gnomad EAS
AF:
0.822
Gnomad SAS
AF:
0.575
Gnomad FIN
AF:
0.553
Gnomad MID
AF:
0.658
Gnomad NFE
AF:
0.574
Gnomad OTH
AF:
0.631
GnomAD2 exomes
AF:
0.604
AC:
151063
AN:
250244
AF XY:
0.597
show subpopulations
Gnomad AFR exome
AF:
0.844
Gnomad AMR exome
AF:
0.532
Gnomad ASJ exome
AF:
0.611
Gnomad EAS exome
AF:
0.834
Gnomad FIN exome
AF:
0.552
Gnomad NFE exome
AF:
0.574
Gnomad OTH exome
AF:
0.579
GnomAD4 exome
AF:
0.580
AC:
845558
AN:
1457608
Hom.:
248811
Cov.:
39
AF XY:
0.580
AC XY:
420389
AN XY:
725372
show subpopulations
African (AFR)
AF:
0.848
AC:
28370
AN:
33442
American (AMR)
AF:
0.534
AC:
23868
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.609
AC:
15912
AN:
26112
East Asian (EAS)
AF:
0.800
AC:
31763
AN:
39684
South Asian (SAS)
AF:
0.568
AC:
48961
AN:
86174
European-Finnish (FIN)
AF:
0.548
AC:
29173
AN:
53228
Middle Eastern (MID)
AF:
0.604
AC:
3477
AN:
5760
European-Non Finnish (NFE)
AF:
0.566
AC:
627660
AN:
1108256
Other (OTH)
AF:
0.604
AC:
36374
AN:
60248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
17913
35826
53738
71651
89564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17498
34996
52494
69992
87490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.649
AC:
98624
AN:
152028
Hom.:
33155
Cov.:
32
AF XY:
0.645
AC XY:
47896
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.832
AC:
34494
AN:
41468
American (AMR)
AF:
0.542
AC:
8280
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.610
AC:
2118
AN:
3470
East Asian (EAS)
AF:
0.822
AC:
4240
AN:
5158
South Asian (SAS)
AF:
0.574
AC:
2757
AN:
4806
European-Finnish (FIN)
AF:
0.553
AC:
5838
AN:
10554
Middle Eastern (MID)
AF:
0.656
AC:
193
AN:
294
European-Non Finnish (NFE)
AF:
0.574
AC:
39049
AN:
67980
Other (OTH)
AF:
0.630
AC:
1331
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1675
3350
5024
6699
8374
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.631
Hom.:
13308
Bravo
AF:
0.659
Asia WGS
AF:
0.720
AC:
2503
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
14
DANN
Benign
0.92
PhyloP100
0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4072883; hg19: chr9-137686906; COSMIC: COSV65667137; API